Pfizer going 'all in' on obesity drug development, CEO Bourla says-June 2024-www.financetom.com

Pfizer going 'all in' on obesity drug development, CEO Bourla says

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Pfizer going 'all in' on obesity drug development, CEO Bourla says

Jan 13, 2025 11:10 AM

Jan 13 (Reuters) - U.S. drugmaker Pfizer ( PFE ) is going "all in" to develop its

experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive

Officer Albert Bourla said at the JPMorgan Healthcare conference on Monday.

Previous page： CBRE, EV+ Collaborate on EV Charging Network Expansion Next page： Celestica's Proposed US$500 Million Term Loan B Assigned Rating by S&P

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

CBRE, EV+ Collaborate on EV Charging Network Expansion

May 16, 2024

10:19 AM EDT, 05/16/2024 (MT Newswires) -- CBRE Group ( CBRE ) is partnering with privately held EV+ to install electric vehicle charging systems at 10,000 commercial properties over the next five years, the companies said on Thursday. CBRE ( CBRE ) will assist EV+ with site acquisition and project management in addition to securing grants and other financial incentives...

Celestica's Proposed US$500 Million Term Loan B Assigned Rating by S&P

May 16, 2024

10:18 AM EDT, 05/16/2024 (MT Newswires) -- S&P Global Ratings on Wednesday assigned its BB issue-level rating and 3 recovery rating to Celestica's ( CLS ) proposed US$500 million term loan B. The 3 recovery rating indicates the rating agency's expectation of meaningful recovery in a simulated default scenario. The term loan will rank pari passu in right of payment...

Tredegar's Terphane Sale Faces Regulatory Hurdle in Brazil

May 16, 2024

10:15 AM EDT, 05/16/2024 (MT Newswires) -- Tredegar ( TG ) said Thursday that Brazilian regulators have recommended rejection of the proposed sale of its flexible packaging films business Terphane to Oben Group. Tredegar ( TG ) said in September last year that it had agreed to sell the unit for about $116 million. Tredegar ( TG ) said the...

FAA allows United Airlines to restart certification activities

May 16, 2024

May 16 (Reuters) - United Airlines said on Thursday the U.S. Federal Aviation Administration has permitted the carrier to restart its certification activities, including new aircraft and routes. The airline's certification activities were suspended after the FAA said in March it was increasing its oversight of United following recent safety incidents. The aviation regulator said it would initiate a formal...